The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Are Opioid Contracts Helpful or Harmful?

Are Opioid Contracts Helpful or Harmful?

October 18, 2019 • By Steven M. Harris, Esq.

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Victor Moussa / shutterstock.com

Victor Moussa / shutterstock.com

The opioid epidemic in the U.S. has destroyed thousands of lives and torn families apart. According to the Centers for Disease Control and Prevention, an average of 130 people in the U.S. die each day from an opioid overdose. From 1999 to 2017, more than 700,000 died as a result of drug overdoses. In 2017, the number of overdose deaths involving opioids (both legal prescription and illegal opioids, such as heroin) was six times higher than in 1999.

You Might Also Like
  • U.S. Launches Opioid Fraud and Detection Unit
  • U.S. Life Expectancy Fell in 2016 as Opioid Overdoses Surged—CDC
  • FDA Says It Requires Boxed Warning on Some Opioid-Based Painkillers
Explore This Issue
October 2019
Also By This Author
  • Get Employment Records In Writing

Three distinct waves have defined the increase in opioid overdose deaths. The first wave began in the 1990s and resulted from increased prescriptions by healthcare providers. Overdose deaths involving prescription opioids (natural and semisynthetic opioids and methadone) have increased steadily since 1999. The second wave began in 2010 and was marked by rapid increases in overdose deaths attributable to heroin. The third wave began in 2013 with significant increases in overdose deaths attributable to synthetic opioids, particularly those involving illicitly manufactured fentanyl.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In 2017, the U.S. Department of Health & Human Services declared a public health emergency and announced a five-point strategy to combat the opioid crisis:

  1. Improve access to treatment and recovery services;
  2. Promote the use of overdose-reversing drugs;
  3. Strengthen understanding of the epidemic through better public health surveillance;
  4. Provide support for cutting-edge research on pain and addiction; and
  5. Advance better practices for pain management.

In 2018, the SUPPORT for Patients and Communities Act was passed. This legislation reforms Medicare and Medicaid to better help patients with opioid addictions and promotes national education regarding the risks associated with opioid use.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Many states have also taken action to help reduce the number of opioid overdose deaths. A handful of states now require patients seeking opioid medication for chronic pain to enter into a contract with their providers before a prescription is written. However, a growing school of thought indicates these contracts may do more harm than good.

What Is an Opioid Contract?

The purpose of an opioid contract is to provide information regarding the pros and cons associated with opioid use. A contract is intended to deter abuse, improve the positive outcomes associated with opioid use and minimize the prescribing physician’s risk. As part of the contract, patients must agree to undergo random urine drug screens and pill counts, and to receive opioid prescriptions only from the physician identified in the contract.

By signing, patients agree to abide by the dosing and frequency prescribed, participate in certain programs, not request opioids or other pain medicine from other physicians, participate in mental health assessments if necessary and, to the extent possible, obtain all medications from one pharmacy. The contract typically includes a list of actions that would permit the physician to stop prescribing opioids or change the treatment plan. Finally, the contract usually includes a description of safety risks, potential side effects and tips for medication management.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In short, a contract ensures:

Pages: 1 2 | Single Page

Filed Under: Legal Tagged With: opioid contracts, opioid crisis, physician patient relationshipIssue: October 2019

You Might Also Like:
  • U.S. Launches Opioid Fraud and Detection Unit
  • U.S. Life Expectancy Fell in 2016 as Opioid Overdoses Surged—CDC
  • FDA Says It Requires Boxed Warning on Some Opioid-Based Painkillers
  • Monitoring Doctors Cuts Opioid Prescriptions

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.